A J Marozsan
Overview
Explore the profile of A J Marozsan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
199
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu Z, Qi S, Lasaro M, Bouchard K, Dow C, Moore K, et al.
Am J Transplant
. 2016 Mar;
16(9):2589-97.
PMID: 27003920
The complement system plays a critical role in ischemia-reperfusion injury (IRI)-mediated delayed graft function (DGF). To better understand the roles of complement activation pathways in IRI in kidney transplantation, donor...
2.
Marozsan A, Torre V, Johnson M, Ball S, Cross J, Templeton D, et al.
J Virol
. 2001 Aug;
75(18):8624-38.
PMID: 11507208
Aminooxypentane (AOP)-RANTES is a potent inhibitor of nonsyncytium-inducing (NSI), CCR5-tropic (R5) human immunodeficiency virus type 1 (HIV-1) isolates. Although classical chemotactic responses are not induced in primary leukocytes by AOP-RANTES,...
3.
Quinones-Mateu M, Ball S, Marozsan A, Torre V, Albright J, Vanham G, et al.
J Virol
. 2000 Sep;
74(19):9222-33.
PMID: 10982369
This study was designed to examine the impact of human immunodeficiency virus type 1 (HIV-1) fitness on disease progression through the use of a dual competition/heteroduplex tracking assay (HTA). Despite...
4.
Torre V, Marozsan A, Albright J, Collins K, Hartley O, Offord R, et al.
J Virol
. 2000 Apr;
74(10):4868-76.
PMID: 10775626
Aminooxypentane (AOP)-RANTES efficiently and specifically blocks entry of non-syncytium-inducing (NSI), CCR5-tropic (R5) human immunodeficiency virus type 1 (HIV-1) into host cells. Inhibition appears to be mediated by increased intracellular retention...